Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
Rank in Stocks #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Share Price
$0.8
Last synced: 2024-01-02
Market Cap
$80.24M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade W World Corp. (WWHC)
Number of shares outstanding for W World Corp. (WWHC)
Number of shares outstanding as of August 2026: 0
According to W World Corp. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for W World Corp. (WWHC) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors